Maravai LifeSciences
MRVI
7.43
-0.42
-5.35%
Maravai LifeSciences
US · MRVI
#3116 by market cap
Listed 2020
7.43
-0.42
-5.35%
Live - 5344 symbols - heartbeat 504s ago
· 2026-10-08 07:41
Pre-market
7.64
+2.83%
After-hours
7.44
+0.13%
- Market cap
- 1.11B
- P/E (TTM)i
- -14.02
- P/Bi
- 5.41
- EPSi
- -0.90
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on MRVI?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 5 analysts
Buy
Avg price target
7.83 +5.4%
Price target rangecurrent 7.43
Low6.50
Avg7.83
High9.00
Buy 80%
Hold 20%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | TD Cowen | -- | BUY | 9.00 |
| 2026-09-15 | Craig-Hallum | -- | BUY | -- |
| 2026-08-11 | Stifel | -- | BUY | 8.00 |
| 2026-08-07 | Wells Fargo | -- | BUY | 6.50 |
| 2026-08-07 | William Blair | -- | HOLD | -- |
| 2026-05-11 | Stifel | -- | BUY | 6.00 |
| 2026-05-11 | Guggenheim | -- | HOLD | -- |
| 2026-05-08 | William Blair | -- | HOLD | -- |
| 2026-05-08 | Craig-Hallum | -- | BUY | 5.00 |
| 2026-05-08 | Deutsche Bank | -- | BUY | 6.00 |
| 2026-04-23 | Craig-Hallum | -- | BUY | -- |
| 2026-04-20 | Craig-Hallum | -- | BUY | -- |
| 2026-02-27 | Stifel | -- | BUY | 4.00 |
| 2026-02-26 | William Blair | -- | HOLD | -- |
| 2026-02-26 | Craig-Hallum | -- | BUY | -- |
| 2026-02-25 | Guggenheim | -- | HOLD | -- |
| 2026-02-23 | Craig-Hallum | -- | BUY | -- |
| 2026-02-13 | Craig-Hallum | -- | BUY | -- |
| 2026-01-28 | Craig-Hallum | -- | BUY | -- |
| 2026-01-23 | Craig-Hallum | -- | BUY | -- |
| 2026-01-05 | Craig-Hallum | -- | BUY | -- |
| 2025-12-15 | Wells Fargo | -- | BUY | 4.50 |
| 2025-12-10 | Craig-Hallum | -- | BUY | -- |
| 2025-11-14 | Craig-Hallum | -- | BUY | -- |
| 2025-11-10 | Craig-Hallum | -- | BUY | -- |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±27.43% | -0.32% (in line) |
| 2026/Q1 | 2026-05-07 | After close | -- | +23.10% |
| 2025/Q4 | 2026-02-25 | After close | ±25.72% | +9.20% (in line) |
| 2025/Q3 | 2025-11-06 | After close | -- | -0.69% |
| 2025/Q2 | 2025-08-11 | After close | ±24.51% | +30.58% (beat) |
| 2025/Q1 | 2025-05-12 | After close | ±25.47% | -2.83% (in line) |
| 2024/Q4 | 2025-03-18 | After close | ±19.38% | -5.81% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±31.22% | -35.27% (beat) |
| 2024/Q2 | 2024-08-07 | After close | ±13.94% | -6.87% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±25.36% | +11.16% (in line) |
| 2023/Q4 | 2024-02-22 | After close | ±23.87% | +63.60% (beat) |
| 2023/Q3 | 2023-11-07 | After close | ±20.35% | -31.69% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:41:32 · For reference only, not investment advice and not tailored to your situation.